Check the Batch
Class IIITerminated in FDA datasetRecall initiated May 6, 2019

Item FG 10190, Barleans Full Spectrum Hemp Extract, 60 Softgels per bottle.

Recalling firm: Barlean's Llc

Why it was recalled

Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Oct 15, 2020.

Check your package

Compare the exact product and package details with the label you have.

ProductItem FG 10190, Barleans Full Spectrum Hemp Extract, 60 Softgels per bottle. UPC 7 05875 80113 3. Item FG 10193, Barleans Full Spectrum Hemp Extract, 30 Softgels per bottle. UPC 7 05875 80115 7.
UPC705875801133, 705875801157

FDA code information

Best By of January 2021 and earlier

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Item FG 10190, Barleans Full Spectrum Hemp Extract, 60 Softgels per bottle. UPC 7 05875 80113 3. Item FG 10193, Barleans Full Spectrum Hemp Extract, 30 Softgels per bottle. UPC 7 05875 80115 7.

Extracted codes and context

TypeCode / valueContext
UPC705875801133tem FG 10190, Barleans Full Spectrum Hemp Extract, 60 Softgels per bottle. UPC 7 05875 80113 3. Item FG 10193, Barleans Full Spectrum Hemp Extract, 30 Softgels per bottle. UPC 7 05875 80115 7.
UPC705875801157tem FG 10193, Barleans Full Spectrum Hemp Extract, 30 Softgels per bottle. UPC 7 05875 80115 7.

Original FDA recall reason

Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.

Recall details

Recall number
F-1368-2019
Event ID
82565
FDA status
Terminated
Initiated
May 6, 2019
Reported
May 22, 2019
Classified
May 16, 2019
Terminated
Oct 15, 2020
Quantity
firm did not provide
Location
Ferndale, WA, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

nationwide

FDA source record · F-1368-2019

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.